Literature DB >> 25898835

Alpha-melanocyte stimulating hormone inhibits monocytes adhesion to vascular endothelium.

Yang Yang1, Weihua Zhang1, Lin Meng1, Haitao Yu1, Na Lu1, Gang Fu1, Yang Zheng2.   

Abstract

Inflammation and its subsequent endothelial dysfunction have been reported to play a pivotal role in the initiation and progression of chronic vascular diseases. Inhibiting the attachment of monocytes to endothelium is a potential therapeutic strategy for vascular diseases treatment. α-Melanocyte stimulating hormone is generated from a precursor hormone called proopiomelanocortin by post-translational processing. However, whether α-melanocyte stimulating hormone plays a role in regulating endothelial inflammation is still unknown. In this study, the effects of α-melanocyte stimulating hormone on endothelial inflammation in human umbilical vein endothelial cell lines were investigated. And the result indicated that α-melanocyte stimulating hormone inhibits the expression of endothelial adhesion molecules, including vascular adhesion molecule-1 and E-selectin, thereby attenuating the adhesion of THP-1 cells to the surface of endothelial cells. Mechanistically, α-melanocyte stimulating hormone was found to inhibit NF-κB transcriptional activity. Finally, we found that the effect of α-melanocyte stimulating hormone on endothelial inflammation is dependent on its receptor melanocortin receptor 1.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  NF-κB; VCAM-1; endothelial inflammation; α-Melanocyte stimulating hormone

Mesh:

Substances:

Year:  2015        PMID: 25898835      PMCID: PMC4935305          DOI: 10.1177/1535370215581307

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  19 in total

1.  Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice.

Authors:  L A Rheins; A L Cotleur; R S Kleier; W B Hoppenjans; D N Saunder; J J Nordlund
Journal:  J Invest Dermatol       Date:  1989-10       Impact factor: 8.551

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.

Authors:  Markus Böhm; Thomas A Luger; Desmond J Tobin; José Carlos García-Borrón
Journal:  J Invest Dermatol       Date:  2006-09       Impact factor: 8.551

Review 4.  The role of alpha-melanocyte-stimulating hormone in cutaneous biology.

Authors:  T A Luger; T Scholzen; S Grabbe
Journal:  J Investig Dermatol Symp Proc       Date:  1997-08

5.  Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH).

Authors:  A W Taylor; D G Yee; T Nishida; K Namba
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

6.  Molecular basis of the alpha-MSH/IL-1 antagonism.

Authors:  T Brzoska; D H Kalden; T Scholzen; T A Luger
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

7.  Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals.

Authors:  Maria Annunziata Carluccio; Luisa Siculella; Maria Assunta Ancora; Marika Massaro; Egeria Scoditti; Carlo Storelli; Francesco Visioli; Alessandro Distante; Raffaele De Caterina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-20       Impact factor: 8.311

8.  MC1R expression in HaCaT keratinocytes inhibits UVA-induced ROS production via NADPH oxidase- and cAMP-dependent mechanisms.

Authors:  Pauline Henri; Sylvain Beaumel; Anne Guezennec; Carine Poumès; Pierre-Emmanuel Stoebner; Marie-José Stasia; Joëlle Guesnet; Jean Martinez; Laurent Meunier
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 9.  Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.

Authors:  René R S Packard; Peter Libby
Journal:  Clin Chem       Date:  2008-01       Impact factor: 8.327

10.  alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice.

Authors:  S Grabbe; R S Bhardwaj; K Mahnke; M M Simon; T Schwarz; T A Luger
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

View more
  3 in total

1.  Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages.

Authors:  Petteri Rinne; Martina Rami; Salla Nuutinen; Donato Santovito; Emiel P C van der Vorst; Raquel Guillamat-Prats; Leo-Pekka Lyytikäinen; Emma Raitoharju; Niku Oksala; Larisa Ring; Minying Cai; Victor J Hruby; Terho Lehtimäki; Christian Weber; Sabine Steffens
Journal:  Circulation       Date:  2017-04-27       Impact factor: 29.690

Review 2.  Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses.

Authors:  Caterina Lonati; Stefano Gatti; Anna Catania
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-10       Impact factor: 5.555

3.  αMSH inhibits adipose inflammation via reducing FoxOs transcription and blocking Akt/JNK pathway in mice.

Authors:  Guannv Liu; Meihang Li; Muhammad Saeed; Yatao Xu; Qian Ren; Chao Sun
Journal:  Oncotarget       Date:  2017-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.